These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35835469)

  • 1. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
    Damato V; Spagni G; Monte G; Woodhall M; Jacobson L; Falso S; Smith T; Iorio R; Waters P; Irani SR; Vincent A; Evoli A
    J Neurol Neurosurg Psychiatry; 2022 Sep; 93(9):995-1000. PubMed ID: 35835469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
    Spagni G; Gastaldi M; Businaro P; Chemkhi Z; Carrozza C; Mascagna G; Falso S; Scaranzin S; Franciotta D; Evoli A; Damato V
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36270951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
    Huda S; Woodhall MR; Vincent A; Heckmann JM
    Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.
    Rodríguez Cruz PM; Al-Hajjar M; Huda S; Jacobson L; Woodhall M; Jayawant S; Buckley C; Hilton-Jones D; Beeson D; Vincent A; Leite MI; Palace J
    JAMA Neurol; 2015 Jun; 72(6):642-9. PubMed ID: 25894002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
    Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
    Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.
    Hoffmann S; Waters P; Jacobson L; Schuelke M; Stenzel W; Ruck T; Lehnerer S; Stascheit F; Preuße C; Meisel A
    Neuromuscul Disord; 2023 Feb; 33(2):139-144. PubMed ID: 36746691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
    Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
    J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
    Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH
    J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in Japanese patients with ocular myasthenia gravis.
    Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
    Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving laboratory diagnostics in myasthenia gravis.
    Gastaldi M; Scaranzin S; Businaro P; Mobilia E; Benedetti L; Pesce G; Franciotta D
    Expert Rev Mol Diagn; 2021 Jun; 21(6):579-590. PubMed ID: 33970749
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical need for clustered AChR cell-based assay testing of seronegative MG.
    Masi G; Li Y; Karatz T; Pham MC; Oxendine SR; Nowak RJ; Guptill JT; O'Connor KC
    J Neuroimmunol; 2022 Jun; 367():577850. PubMed ID: 35366559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
    Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
    J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to agrin in myasthenia gravis patients.
    Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
    PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
    Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
    Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.